Efficacy and safety of aztreonam-clindamycin versus tobramycin-clindamycin in the treatment of lower respiratory tract infections caused by aerobic gram-negative bacilli.

Podobne knjige/članki

• Multidrug resistant Gram-negative bacilli in lower respiratory tract infections
  od: Vishwanath, Shashidhar, et al.
  Izdano: (2013)
• Is There Complete Cross-Resistance of Gram-Negative Bacilli to Gentamicin and Tobramycin?
  od: Crowe, C. C., et al.
  Izdano: (1972)
• Bacteriological Profile and Antibiotic Susceptibility Patterns of Gram-negative Bacilli Isolated from Lower Respiratory Tract Infections
  od: Divya Atray, et al.
  Izdano: (2023-01-01)
• In Vitro Activity of Plazomicin Compared to Amikacin, Gentamicin, and Tobramycin against Multidrug-Resistant Aerobic Gram-Negative Bacilli
  od: Fleischmann, Wim A., et al.
  Izdano: (2020)
• Activities of aztreonam and new cephalosporins against infrequently isolated gram-negative bacilli.
  od: Strandberg, D A, et al.
  Izdano: (1983)